vs
Immunovant, Inc.（IMVT）与EVERSPIN TECHNOLOGIES INC.（MRAM）财务数据对比。点击上方公司名可切换其他公司
EVERSPIN TECHNOLOGIES INC.的季度营收约是Immunovant, Inc.的1.8倍（$14.9M vs $8.4M），EVERSPIN TECHNOLOGIES INC.净利率更高（-2.0% vs -899.0%，领先897.0%），Immunovant, Inc.同比增速更快（140.7% vs 13.2%）
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
Everspin Technologies是一家总部位于美国亚利桑那州钱德勒的上市半导体企业，核心业务为研发生产磁阻随机存取存储器（MRAM）产品，涵盖Toggle MRAM与自旋转移矩MRAM两大产品系列，同时也对外授权嵌入式MRAM、磁传感器相关技术，并提供嵌入式MRAM后道代工服务。
IMVT vs MRAM — 直观对比
营收规模更大
MRAM
是对方的1.8倍
$8.4M
营收增速更快
IMVT
高出127.5%
13.2%
净利率更高
MRAM
高出897.0%
-899.0%
损益表 — Q4 FY2024 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $8.4M | $14.9M |
| 净利润 | $-75.3M | $-296.0K |
| 毛利率 | — | 52.7% |
| 营业利润率 | -896.2% | 29.0% |
| 净利率 | -899.0% | -2.0% |
| 营收同比 | 140.7% | 13.2% |
| 净利润同比 | -26.7% | — |
| 每股收益（稀释后） | $-0.50 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMVTMRAM
| Q1 26 | — | $14.9M | ||
| Q4 25 | — | $14.8M | ||
| Q3 25 | — | $14.1M | ||
| Q2 25 | — | $13.2M | ||
| Q1 25 | — | $13.1M | ||
| Q4 24 | — | $13.2M | ||
| Q3 24 | — | $12.1M | ||
| Q2 24 | — | $10.6M |
净利润IMVTMRAM
| Q1 26 | — | $-296.0K | ||
| Q4 25 | — | $1.2M | ||
| Q3 25 | — | $54.0K | ||
| Q2 25 | — | $-670.0K | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $-2.5M |
毛利率IMVTMRAM
| Q1 26 | — | 52.7% | ||
| Q4 25 | — | 50.8% | ||
| Q3 25 | — | 51.3% | ||
| Q2 25 | — | 51.3% | ||
| Q1 25 | — | 51.4% | ||
| Q4 24 | — | 51.3% | ||
| Q3 24 | — | 49.2% | ||
| Q2 24 | — | 49.0% |
营业利润率IMVTMRAM
| Q1 26 | — | 29.0% | ||
| Q4 25 | — | -7.2% | ||
| Q3 25 | — | -11.0% | ||
| Q2 25 | — | -14.9% | ||
| Q1 25 | — | -14.7% | ||
| Q4 24 | — | -11.8% | ||
| Q3 24 | — | -17.5% | ||
| Q2 24 | — | -26.5% |
净利率IMVTMRAM
| Q1 26 | — | -2.0% | ||
| Q4 25 | — | 8.1% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | -5.1% | ||
| Q1 25 | — | -8.9% | ||
| Q4 24 | — | 9.2% | ||
| Q3 24 | — | 18.8% | ||
| Q2 24 | — | -23.5% |
每股收益（稀释后）IMVTMRAM
| Q1 26 | — | $-0.01 | ||
| Q4 25 | — | $0.05 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $40.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $617.8M | $70.2M |
| 总资产 | $666.4M | $83.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMVTMRAM
| Q1 26 | — | $40.5M | ||
| Q4 25 | — | $44.5M | ||
| Q3 25 | — | $45.3M | ||
| Q2 25 | — | $45.0M | ||
| Q1 25 | — | $42.2M | ||
| Q4 24 | — | $42.1M | ||
| Q3 24 | — | $39.6M | ||
| Q2 24 | — | $36.8M |
股东权益IMVTMRAM
| Q1 26 | — | $70.2M | ||
| Q4 25 | — | $68.9M | ||
| Q3 25 | — | $65.8M | ||
| Q2 25 | — | $64.1M | ||
| Q1 25 | — | $63.0M | ||
| Q4 24 | — | $62.6M | ||
| Q3 24 | — | $59.3M | ||
| Q2 24 | — | $55.4M |
总资产IMVTMRAM
| Q1 26 | — | $83.2M | ||
| Q4 25 | — | $84.6M | ||
| Q3 25 | — | $80.3M | ||
| Q2 25 | — | $78.9M | ||
| Q1 25 | — | $80.2M | ||
| Q4 24 | — | $77.8M | ||
| Q3 24 | — | $72.6M | ||
| Q2 24 | — | $64.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $570.0K |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | — |
| 自由现金流率自由现金流/营收 | -714.4% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-214.6M | — |
8季度趋势，按日历期对齐
经营现金流IMVTMRAM
| Q1 26 | — | $570.0K | ||
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $881.0K | ||
| Q2 25 | — | $5.0M | ||
| Q1 25 | — | $1.4M | ||
| Q4 24 | — | $3.8M | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | — | $1.7M |
自由现金流IMVTMRAM
| Q1 26 | — | — | ||
| Q4 25 | — | $-975.0K | ||
| Q3 25 | — | $543.0K | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $527.0K | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | — | $1.7M |
自由现金流率IMVTMRAM
| Q1 26 | — | — | ||
| Q4 25 | — | -6.6% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 22.9% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 15.8% | ||
| Q3 24 | — | 22.9% | ||
| Q2 24 | — | 15.9% |
资本支出强度IMVTMRAM
| Q1 26 | — | — | ||
| Q4 25 | — | 24.3% | ||
| Q3 25 | — | 2.4% | ||
| Q2 25 | — | 15.1% | ||
| Q1 25 | — | 6.9% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.3% |
现金转化率IMVTMRAM
| Q1 26 | — | — | ||
| Q4 25 | — | 2.19× | ||
| Q3 25 | — | 16.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.16× | ||
| Q3 24 | — | 1.25× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMVT
暂无分部数据
MRAM
| Product sales | $14.1M | 95% |
| Licensing, royalty, patent, engineering services and other revenue | $772.0K | 5% |
